Scientific Advisory Board

QuIP’s Scientific Advisory Board

The scientific advisory board is an advisory body for QuIP GmbH. The advisory board discusses all relevant issues as well as developments and drafts recommendations for the shareholders. Decisions of the scientific advisory board are of a consultative nature for the shareholders and the management. The members of the advisory board have proven expertise in the field of quality assurance, especially in pathology, are recognized experts in several tumor entities and have many years of experience in the conception and implementation of proficiency testing.

The recommendations of the advisory board are put into effect by approval of the shareholders. The advisory board consists of a maximum of eight voting members; non-voting members are the chairperson of the German Society of Pathology (DGP), the president of the Professional Association of German Pathologists (BDP), the representative of pathology of the German Accreditation Body (DAkkS) and the spokesperson of the Oncology Pathology Working Group (AOP) within the German Cancer Society (DKG). 

The scientific advisory board determines, among other things, the lead panel and panel institutes and usually convenes twice a year.

Members of the Scientific Advisory Board

  • Prof. Dr. med. Claudia Wickenhauser (Chairperson - Pathology, University Hospital Halle)
  • Prof. Dr. med. Hans-Ulrich Schildhaus (Registered Pathologist, Kassel)
  • Prof. Dr. med. Hans-H. Kreipe (Pathology, Hannover Medical School)
  • Prof. Dr. med. Markus J. Riemenschneider (Neuropathology, University Hospital Regensburg)
  • Prof. Dr. med. Klaus Junker (Registered Pathologist, MVZ Hamburg)
  • Prof. Dr. rer. nat. Sabine Merkelbach-Bruse (Pathology, University Hospital Cologne)
  • Dr. med. Andreas Turzynski (Registered Pathologist, Lübeck)
  • Prof. Dr. med. Aurel Perren (Pathology, University of Bern)
  • Prim. Univ.-Prof. Dr. Karl Sotlar (Pathology, University Hospital Salzburg)
  • Dipl.-Biol. Nicole Pfarr (Pathology, Technical University of Munich)
  • Prof. Dr. med. Rainer Grobholz (Pathology, Cantonal Hospital Aarau)

Shareholders QuIP GmbH

  • Prof. Dr. med. Christoph Röcken (Chairperson DGP - Pathology, University Hospital Kiel)
  • Prof. Dr. med. Ludwig Wilkens (President BDP - Pathology, Hannover Region Hospital)

Guests

  • Prof. Dr. med. Arndt Hartmann (Pathology Representative of the German accreditation body (DAkkS) and the Arbeitsgemeinschaft Onkologische Pathologie, University Hospital Erlangen)
  • Dr. rer. nat. Vanessa Kääb-Sanyal (BDP)
  • Jörg Maas (DGP)
  • Thomas Pilz (QuIP)

Version: 01/2025